Gene · 23643
Papers4,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis. | Int J Mol Sci | 2023 | 37894850 | PubTator, text mining | PubMed |
| Advance in Neurotoxicity Research from Development to Aging. | Int J Mol Sci | 2023 | 37894793 | PubTator, text mining | PubMed |
| S100 Proteins in the Pathogenesis of Psoriasis and Atopic Dermatitis. | Diagnostics (Basel) | 2023 | 37891988 | PubTator, text mining | PubMed |
| Comprehensive analyses identify potential biomarkers for encephalitis in HIV infection. | Sci Rep | 2023 | 37891420 | PubTator, text mining | PubMed |
| Dissecting the innate immune recognition of morphine and its metabolites by TLR4/MD2: an in silico simulation study. | Phys Chem Chem Phys | 2023 | 37882236 | PubTator, text mining | PubMed |
| Quantification of training load across two competitive seasons in elite senior and youth male soccer players from an English Premiership club. | Biol Sport | 2023 | 37867738 | PubTator, text mining | PubMed |
| Unraveling The Effects of DICER1 Overexpression on Immune-Related Genes Expression in Mesenchymal Stromal/Stem Cells: Insights for Therapeutic Applications. | Cell J | 2023 | 37865878 | PubTator, text mining | PubMed |
| Extracellular vesicles of the probiotic bacteria E. coli O83 activate innate immunity and prevent allergy in mice. | Cell Commun Signal | 2023 | 37864211 | PubTator, text mining | PubMed |
| Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma. | Aging (Albany NY) | 2023 | 37862109 | PubTator, text mining | PubMed |
| The role of endotoxin in septic shock. | Crit Care | 2023 | 37858258 | PubTator, text mining | PubMed |
| Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles. | Front Immunol | 2023 | 37841267 | PubTator, text mining | PubMed |
| Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID). | Front Immunol | 2023 | 37841257 | PubTator, text mining | PubMed |
| New insights into intestinal macrophages in necrotizing enterocolitis: the multi-functional role and promising therapeutic application. | Front Immunol | 2023 | 37841247 | PubTator, text mining | PubMed |
| Pharmacological Mechanisms and Adjuvant Properties of Licorice Glycyrrhiza in Treating Gastric Cancer. | Molecules | 2023 | 37836809 | PubTator, text mining | PubMed |
| Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives. | Front Immunol | 2023 | 37822929 | PubTator, text mining | PubMed |
| Are non-starters accumulating enough load compared with starters? Examining load, wellness, and training/match ratios of a European professional soccer team. | BMC Sports Sci Med Rehabil | 2023 | 37817275 | PubTator, text mining | PubMed |
| Human iPSC-derived glia models for the study of neuroinflammation. | J Neuroinflammation | 2023 | 37817184 | PubTator, text mining | PubMed |
| [Identification and preliminary validation of potential biomarkers in the peripheral blood mononuclear cells of atopic dermatitis]. | Zhonghua Yi Xue Za Zhi | 2023 | 37813654 | PubTator, text mining | PubMed |
| Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity. | ACS Omega | 2023 | 37810727 | PubTator, text mining | PubMed |
| Nanoparticles targeting monocytes and macrophages as diagnostic and therapeutic tools for autoimmune diseases. | Heliyon | 2023 | 37810138 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23643/papers?page=17